Stempeutics

Pawan Gupta, M.D., Ph.D., SVP, Medical and Regulatory Affairs
Bangalore, India
(Private)
Stempeutics Research Bangalore is a late-stage life science company focused on developing and commercializing novel therapeutics based on adult stem cells. The company’s flagship product is Stempeucel® drug, an on-demand, off-the-shelf product based on pooled, allogeneic Mesenchymal Stromal Cells derived from bone marrow of healthy, adult volunteers. Stempeucel® is being developed for the treatment of Critical Limb Ischemia (CLI), Osteoarthritis (OA), Diabetic Foot Ulcer (DFU) Perianal fistuala due to Crohn’s disease and ARDS due to COVID 19. In 2017, DCGI granted manufacturing and marketing approval for Stempeucel® product for the treatment of CLI due to Buerger’s disease patients.
www.stempeutics.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions